Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A Mediterranean diet could help reduce the risk of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
The incidence rate is expected to be especially high among young women with alcoholic liver disease.
Despite new guidelines, too few infants born to mothers with hepatitis C were screened for the virus.
Areas with lower population density have not seen the same slowdown as urban areas.
Optimal treatment for fatty liver disease may involve combining drugs with different mechanisms of action.
Readily available clinical parameters can identify those at greatest risk for hepatocellular carcinoma.
Many people with fatty liver disease have obesity, diabetes and other metabolic conditions.
Hepatitis A and B can be prevented with vaccines, and hepatitis C can be cured with antiviral treatment.
However, people with cirrhosis alone were as likely to die as those with both cirrhosis and COVID-19.
Liver scarring was associated with poorer health outcomes and a higher risk of death for people with non-alcoholic fatty liver disease.
Transplants due to hepatitis C have declined dramatically thanks to effective treatment.
Those with fatty liver disease and cirrhosis should undergo regular screening.
Three fatty liver disease candidates miss the mark for effectiveness or safety.
People with liver cirrhosis often have substantial financial burden that interferes with their care.
The link between diabetes and liver disease
Researchers have presented findings from the first large cohort of people followed over a lengthy period to assess this connection.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.